Legend Biotech (LEGN) Gains from Sales and Divestitures (2021 - 2025)
Legend Biotech (LEGN) posted Gains from Sales and Divestitures of $250000.0 for Q2 2025, up 371.7% on a QoQ basis from $53000.0 in Q1 2025, and up 12400.0% year-over-year from N/an in Q2 2024.
Legend Biotech (LEGN) has 5 years of Gains from Sales and Divestitures data on file, last reported at $250000.0 in Q2 2025.
- In Q2 2025, Gains from Sales and Divestitures rose 12400.0% year-over-year to $250000.0; the TTM figure through Jun 2025 stood at $250000.0 (up 12400.0% YoY), while the FY2022 annual figure was $481000.0, down 50.62% from the prior year.
- Gains from Sales and Divestitures rose to $250000.0 in Q2 2025, from $53000.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $481000.0 in Q4 2022 and bottomed at $2000.0 in Q1 2024.
- A 5-year average of $102307.7 and a median of $53000.0 in 2025 frame the typical range for Gains from Sales and Divestitures.
- Annual changes were most pronounced in 2024 — Gains from Sales and Divestitures tumbled 99.1% — and 2025, when it soared 12400.0%.
- Year by year, Gains from Sales and Divestitures stood at $54000.0 in 2021, then jumped by 790.74% to $481000.0 in 2022, then sank by 53.64% to $223000.0 in 2023, then tumbled by 99.1% to $2000.0 in 2024, then soared by 12400.0% to $250000.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $250000.0 (Q2 2025), $53000.0 (Q1 2025), and $2000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 250,000.00 |
| Jun 30, 2025 | 250,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Sep 30, 2023 | 223,000.00 |
| Sep 30, 2023 | 223,000.00 |
| Jun 30, 2023 | 141,000.00 |
| Jun 30, 2023 | 141,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 481,000.00 |
| Dec 31, 2022 | 481,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Mar 31, 2021 | 54,000.00 |
| Mar 31, 2021 | 54,000.00 |